Myconostica Ltd Closes Oversubscribed $7.7 Million Round and Establishes US Headquarters in Charleston
Charleston, SC and Manchester UK– Myconostica Ltd, a Manchester UK-based medical diagnostic company specializing in rapid and highly specific tests for life-threatening fungal infections, today announces that it has closed an $7.7 million (£3.9M) oversubscribed round of financing from a number of leading international private equity investors. The new funds will be used to launch the company’s first two products and establish new US headquarters in Charleston, SC. (more…)

